Skip to content
Friday, November 13, 2026
London Wildlife Trust

Administering Stem Cells in Utero to Infants with Neural Tube Defect Enhances Life Outcomes, Study Reveals

A pioneering clinical study has found that administering stem cells to fetuses suffering from spina bifida as part of a surgical repair could constitute a "major milestone" in addressing congenital conditions.

Trial Details and Safety

The US-based trial focused on six fetuses with the 'open' form of spina bifida. Doctors administered regenerative cells sourced from the maternal placenta to the surface of the baby's spinal cord while the defect was being closed.

Significantly, the cell therapy was found to be safe. The study team reported that the treatment did not lead to cancerous growths, interfere with wound healing, or block the correction of co-occurring hindbrain herniation.

Promising Outcomes

Imaging conducted after delivery indicated a full resolution of brainstem displacement in all six infants. This brain structure normalization is strongly associated with enhanced physical outcomes.

"Should it enable more children to achieve ambulation who otherwise would not, then it would become the conventional approach," said the lead researcher. "The results are profoundly encouraging and open the door to lots of potential innovative interventions."

Long-Term Prospects and Optimism

Independent medical specialists proposed that further confirmation of these apparent benefits could announce a "different age" in fetal surgery. The potential to improve neurological damage present before birth is viewed as a paradigm-shifting aim.

Especially significant would be improvements in urogenital and gastrointestinal outcomes, which are common challenges for those diagnosed with this disorder.

Looking Ahead

While this initial trial was small in scale, its confirmed tolerability and hopeful trends offer a robust platform for broader investigative efforts. The integration of stem cell therapy with proven prenatal surgical methods presents significant potential for improving the prognosis for infants diagnosed prenatally with this neural tube defect.

RK
About the author

Robert Krause

Eleanor Greenway is a passionate conservationist and writer, dedicated to sharing stories about urban wildlife and environmental stewardship in London.

London Wildlife Trust

Type to search articles.